Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asepsis01:28

Asepsis

3.6K
The condition of being free from disease-causing living pathogens is asepsis. Aseptic techniques include a set of standard practices to achieve asepsis. An example is the regular environmental cleaning of all parts of the healthcare facility and hand hygiene at home before preparing or eating food. Medical and surgical asepsis in healthcare practice protects patients from harmful pathogens, minimizes the risk of contamination of susceptible sites, and reduces the risk of infection transmission.
3.6K
Cleaning, Sterilization, and Disinfection01:30

Cleaning, Sterilization, and Disinfection

12.3K
Cleaning, disinfection, and sterilization are the methods that help to break the infection chain and prevent disease.
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
12.3K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.6K
Hand hygiene01:23

Hand hygiene

6.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.4K
Standard Precaution01:26

Standard Precaution

3.3K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
3.3K
Discharge Summary Forms01:31

Discharge Summary Forms

1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sterility Assurance-Current and Future State.

PDA journal of pharmaceutical science and technology·2021
Same author

Wanted: Dead or Alive.

PDA journal of pharmaceutical science and technology·2021
Same author

The Bugs Don't Lie.

PDA journal of pharmaceutical science and technology·2019
Same author

A Tale of Two Sterilizers.

PDA journal of pharmaceutical science and technology·2019
Same author

Increasing Patient Safety by Closing the Sterile Production Gap-Part 3-Moist Heat Resistance of Bioburden.

PDA journal of pharmaceutical science and technology·2017
Same author

Increasing Patient Safety by Closing the Sterile Production Gap-Part 2. Implementation.

PDA journal of pharmaceutical science and technology·2017

Related Experiment Video

Updated: Mar 8, 2026

A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
20:33

A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing

Published on: July 4, 2019

52.2K

Increasing Patient Safety by Closing the Sterile Production Gap-Part 1. Introduction.

James P Agalloco1

  • 1Agalloco & Associates Inc., 22 Carriage Trail, Belle Mead, NJ 08502 jagalloco@aol.com.

PDA Journal of Pharmaceutical Science and Technology
|January 17, 2017
PubMed
Summary
This summary is machine-generated.

Terminal sterilization for sterile drug products can be optimized by focusing on bioburden destruction, not just biological indicator reduction. This allows for gentler, shorter processes without compromising patient safety.

Keywords:
Aseptic processingBioburdenBiological indicatorProbability of a non-sterile unit (PNSU)RegulationSterility assuranceSterilizationTerminal sterilization

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.6K
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

791

Related Experiment Videos

Last Updated: Mar 8, 2026

A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
20:33

A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing

Published on: July 4, 2019

52.2K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.6K
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

791

Area of Science:

  • Pharmaceutical Manufacturing
  • Sterilization Technologies
  • Microbial Control

Background:

  • Terminal sterilization is the preferred method for sterile drug production due to enhanced patient safety.
  • Current terminal sterilization processes are often unnecessarily harsh due to a misunderstanding of the primary goal.
  • Overly stringent time-temperature requirements limit its application to heat-stable formulations.

Purpose of the Study:

  • To challenge the conventional understanding of terminal sterilization parameters.
  • To propose a scientifically sound approach to optimize terminal sterilization processes.
  • To expand the applicability of terminal sterilization to a wider range of drug products.

Main Methods:

  • Re-evaluation of the core objective of terminal sterilization from biological indicator destruction to bioburden elimination.
  • Analysis of the impact of time-temperature profiles on microbial inactivation within the final container.
  • Development of a framework for scientifically justified process parameter setting.

Main Results:

  • The fixation on destroying highly resistant biological indicators leads to excessively harsh sterilization conditions.
  • The true goal is the destruction of the inherent bioburden present in the drug product.
  • Reduced time-temperature conditions are effective and safe when focused on bioburden destruction.

Conclusions:

  • Terminal sterilization's utility is artificially limited by outdated process expectations.
  • Shifting the focus to bioburden destruction enables the use of milder, more efficient sterilization cycles.
  • Optimized terminal sterilization benefits patients, manufacturers, and regulatory bodies by increasing product availability and safety.